Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2031 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

HGS Presents Results For Lupus Trial

Human Genome Sciences (HGS) has reported the publication of the results of primary endpoint of two pivotal phase 3 clinical trials of Benlysta (belimumab) in serologically active patients

Spectrum Receives FDA Approval For Zevalin

Spectrum Pharmaceuticals (Spectrum) has received FDA approval for Zevalin for an expanded label for the treatment of patients with previously untreated follicular non-Hodgkin’s Lymphoma (NHL), who achieve a